with PEA, modifications to the alpha position prevent reduction [eg amphetamine]: to a lesser extent so does beta substitution. Some pharmaceuticals bind the two, [eg tranylcypromine]. But has anyone ever thought of investigating a double-bond modification to the PEA over the alpha-beta positions to produce phenylethenylamine?
This molecule also has the strange property that if it is bent over onto the phenyl, it produces the indole molecule.
These 2 observations give me reason to suspect high pharmocological activity of PEeA, either DRA and NRA actions, or MAOI actions, quite possibly both. Yet sustained internet investigation produces not results of investigation of this compound.
What possible alterations of physiological effects could one expect from introducing this double bond? A longer-lasting PEA compound? Or something completely different?
This molecule also has the strange property that if it is bent over onto the phenyl, it produces the indole molecule.
These 2 observations give me reason to suspect high pharmocological activity of PEeA, either DRA and NRA actions, or MAOI actions, quite possibly both. Yet sustained internet investigation produces not results of investigation of this compound.
What possible alterations of physiological effects could one expect from introducing this double bond? A longer-lasting PEA compound? Or something completely different?
